Your browser doesn't support javascript.
loading
MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.
Goedeke, Leigh; Rotllan, Noemi; Canfrán-Duque, Alberto; Aranda, Juan F; Ramírez, Cristina M; Araldi, Elisa; Lin, Chin-Sheng; Anderson, Norma N; Wagschal, Alexandre; de Cabo, Rafael; Horton, Jay D; Lasunción, Miguel A; Näär, Anders M; Suárez, Yajaira; Fernández-Hernando, Carlos.
Afiliación
  • Goedeke L; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Rotllan N; Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Canfrán-Duque A; Department of Medicine, Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, New York, USA.
  • Aranda JF; Department of Cell Biology, New York University School of Medicine, New York, New York, USA.
  • Ramírez CM; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Araldi E; Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Lin CS; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Anderson NN; Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Wagschal A; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA.
  • de Cabo R; Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Horton JD; Department of Medicine, Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, New York, USA.
  • Lasunción MA; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Näär AM; Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Suárez Y; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Fernández-Hernando C; Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Nat Med ; 21(11): 1280-9, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26437365
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de LDL / Hepatocitos / MicroARNs / Transportador 1 de Casete de Unión a ATP / HDL-Colesterol / LDL-Colesterol / Hígado Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de LDL / Hepatocitos / MicroARNs / Transportador 1 de Casete de Unión a ATP / HDL-Colesterol / LDL-Colesterol / Hígado Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos